Rx Promotion Remains Potential Political Liability, Attorneys Warn

Pharmaceutical companies should prepare for increased Congressional scrutiny of promotional activities heading into the 2002 mid-term elections, attorney John Kamp (Wiley, Rein and Faulding, Washington, D.C.) told a Drug Information Association marketing workshop.